Silver Rock Financial LP Purchases Shares of 310,000 Acadia Healthcare Company, Inc. $ACHC

Key Points

• Silver Rock Financial LP has acquired 310,000 shares of Acadia Healthcare, amounting to approximately $9.4 million, making it the firm's 4th largest holding.
• Several institutional investors significantly increased their stakes in Acadia Healthcare, with Citigroup Inc. raising its holdings by over 5,144% during the first quarter.
• Acadia Healthcare reported earnings of $0.83 per share for the last quarter, exceeding expectations and showing a 9.2% year-over-year revenue increase.

Silver Rock Financial LP bought a new stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 310,000 shares of the company's stock, valued at approximately $9,399,000. Acadia Healthcare accounts for 2.5% of Silver Rock Financial LP's holdings, making the stock its 4th largest position. Silver Rock Financial LP owned about 0.34% of Acadia Healthcare as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the stock. Hawk Ridge Capital Management LP boosted its stake in shares of Acadia Healthcare by 437.5% during the 1st quarter. Hawk Ridge Capital Management LP now owns 2,473,226 shares of the company's stock valued at $74,988,000 after buying an additional 2,013,126 shares during the period. Citigroup Inc. boosted its stake in shares of Acadia Healthcare by 5,144.2% during the 1st quarter. Citigroup Inc. now owns 2,376,209 shares of the company's stock valued at $72,047,000 after buying an additional 2,330,898 shares during the period. Maverick Capital Ltd. boosted its stake in shares of Acadia Healthcare by 116.3% during the 1st quarter. Maverick Capital Ltd. now owns 2,246,923 shares of the company's stock valued at $68,127,000 after buying an additional 1,208,296 shares during the period. Madison Avenue Partners LP acquired a new stake in shares of Acadia Healthcare in the 4th quarter valued at $76,339,000. Finally, Abrams Bison Investments LLC bought a new position in shares of Acadia Healthcare during the 1st quarter worth about $55,182,000.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on ACHC. Guggenheim dropped their price objective on shares of Acadia Healthcare from $36.00 to $29.00 and set a "buy" rating on the stock in a report on Thursday, August 7th. Cowen reissued a "buy" rating on shares of Acadia Healthcare in a research note on Thursday, August 7th. Royal Bank Of Canada lowered their target price on shares of Acadia Healthcare from $43.00 to $28.00 and set an "outperform" rating on the stock in a research note on Wednesday, August 13th. Raymond James Financial reissued an "outperform" rating and issued a $26.00 target price (down previously from $40.00) on shares of Acadia Healthcare in a research note on Thursday, August 14th. Finally, Mizuho lowered their target price on shares of Acadia Healthcare from $32.00 to $22.00 and set a "neutral" rating on the stock in a research note on Wednesday, August 13th. Eight analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat, Acadia Healthcare has an average rating of "Moderate Buy" and a consensus price target of $39.00.

Acadia Healthcare Price Performance

NASDAQ:ACHC traded down $0.54 on Friday, reaching $21.77. The stock had a trading volume of 976,570 shares, compared to its average volume of 2,226,352. The company has a market capitalization of $2.01 billion, a P/E ratio of 14.44, a price-to-earnings-growth ratio of 4.14 and a beta of 0.89. Acadia Healthcare Company, Inc. has a 1-year low of $17.13 and a 1-year high of $79.82. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.73. The stock has a fifty day moving average price of $22.13 and a 200-day moving average price of $24.43.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. The company reported $0.83 EPS for the quarter, beating analysts' consensus estimates of $0.71 by $0.12. The firm had revenue of $869.23 million for the quarter, compared to analyst estimates of $839.59 million. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.34%. The company's revenue for the quarter was up 9.2% compared to the same quarter last year. During the same period in the previous year, the business earned $0.91 earnings per share. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. Research analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.